Sam Brusco, Associate Editor02.16.21
After an extensive search, Vafa Jamali has been appointed as CEO of "NewCo," an independent, publicly traded company that will be created by a previously announced spin off comprised of the firm’s current Spine and Dental businesses. The spin-off is expected to close in mid-2022.
Jamali was most recently chief commercial officer of Rockley Photonics, where he led commercial strategic planning. Prior to that, he was senior VP and president of Respiratory, Gastrointestinal & Informatics (RGI) at Medtronic.
"Vafa's extensive knowledge and experience in building teams, developing long-term growth strategies, prioritizing resources, driving execution and delivering growth across the medical device industry make him the ideal leader to shape the direction of NewCo and move the business forward," Zimmer Biomet president and CEO Bryan Hanson told the press. "I look forward to partnering with Vafa—and the leadership team that he builds—through this important transition so we can position NewCo for maximum success."
"I'm so excited to join NewCo at this pivotal time in the company's creation," said Jamali. "This is a prime opportunity to leverage my experience in execution and value creation for NewCo. I am looking forward to working closely with the new team to develop and drive investment strategies and a plan for long-term growth in the Spine and Dental markets—all with a relentless focus on delivering for patients, customers, team members and our future shareholders."
Jamali has extensive knowledge in a variety of medical device specialties. Before leading the RGI business, he was senior VP and president of Early Technologies at Medtronic. Prior to Medtronic, he held leadership roles at Covidien, Cardinal Health, and Baxter. Jamali also serves on the Board of Directors for Baylis Medical, a cardiology device manufacturer.
Jamali was most recently chief commercial officer of Rockley Photonics, where he led commercial strategic planning. Prior to that, he was senior VP and president of Respiratory, Gastrointestinal & Informatics (RGI) at Medtronic.
"Vafa's extensive knowledge and experience in building teams, developing long-term growth strategies, prioritizing resources, driving execution and delivering growth across the medical device industry make him the ideal leader to shape the direction of NewCo and move the business forward," Zimmer Biomet president and CEO Bryan Hanson told the press. "I look forward to partnering with Vafa—and the leadership team that he builds—through this important transition so we can position NewCo for maximum success."
"I'm so excited to join NewCo at this pivotal time in the company's creation," said Jamali. "This is a prime opportunity to leverage my experience in execution and value creation for NewCo. I am looking forward to working closely with the new team to develop and drive investment strategies and a plan for long-term growth in the Spine and Dental markets—all with a relentless focus on delivering for patients, customers, team members and our future shareholders."
Jamali has extensive knowledge in a variety of medical device specialties. Before leading the RGI business, he was senior VP and president of Early Technologies at Medtronic. Prior to Medtronic, he held leadership roles at Covidien, Cardinal Health, and Baxter. Jamali also serves on the Board of Directors for Baylis Medical, a cardiology device manufacturer.